Comparison of Next-Generation Sequencing and Ventana Immunohistochemistry in Detecting ALK Rearrangements and Predicting the Efficacy of First-Line Crizotinib in Patients with Advanced Non-Small Cell Lung Cancer

INTRODUCTION: Reliable diagnostic approaches to detect ALK rearrangement are critical for selecting patients eligible for crizotinib therapy. This study aimed to compare next-generation sequencing (NGS) and Ventana immunohistochemistry (IHC) in evaluating ALK rearrangements and evaluate their impact...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Liang, Li, Yizhi, Xu, Qinqin, Jiang, Wenjuan, Lizaso, Analyn, Mao, Xinru, Zhang, Yongchang, Yang, Nong, Wang, Zhenxing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398878/
https://www.ncbi.nlm.nih.gov/pubmed/32801744
http://dx.doi.org/10.2147/OTT.S265974

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398878/
https://www.ncbi.nlm.nih.gov/pubmed/32801744
http://dx.doi.org/10.2147/OTT.S265974

Ejemplares similares